VR
GILD icon

Valued Retirements’s Gilead Sciences GILD Stock Holding History

Valued Retirements’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Buy
2,299
+17
+0.7% +$2.24K 0.26% 75
2026
Q1 		$318K Buy
2,282
+7
+0.3% +$980 0.31% 63
2025
Q4 		$279K Buy
2,275
+53
+2% +$6.44K 0.27% 73
2025
Q3 		$246K Hold
2,222
– – 0.28% 76
2025
Q2 		$246K Buy
+2,222
New +$236K 0.28% 76

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Valued Retirements's GILD Position: Q2 2026 in Review

Valued Retirements increased its Gilead Sciences (GILD) stake by 0.74% in Q2 2026, buying an estimated $2.24K and bringing the position to 2,299 shares worth $290K. The position accounts for 0.26% of the portfolio, ranked #75.

Valued Retirements first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $318K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Valued Retirements held 2,299 shares of Gilead Sciences worth $290K as of Q2 2026.
  • Valued Retirements bought 17 Gilead Sciences shares in Q2 2026, an estimated $2.24K.
  • Gilead Sciences made up 0.26% of Valued Retirements's portfolio in Q2 2026, its #75 holding.
  • Valued Retirements first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Valued Retirements's Gilead Sciences position peaked at $318K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Valued Retirements's 13F filing for Q2 2026, filed 13 Aug 2026.